464
F.M. Ross et al
Development and metabotropic glutamate receptors
LIN, F.F., VARNEY, M., SACAAN, A.I., JACHEC, C., DAGGETT, L.P.,
RAO, S., FLOR, P., KUHN, R., KERNE, R.J.A., STANDAERT, D.,
YOUNG, A.B. & VELICELEBI, G. (1997). Cloning and stable
expression of the mGluR1b subtype of human metabotropic
receptors and pharmacological comparison with the mGluR5a
subtype. Neuropharmacol., 36, 917 ± 931.
PISANI, A., CALABRESI, P., CENTONZE, D. & BERNARDI, G. (1997).
Activation of group III metabotropic glutamate receptors
depresses glutamatergic transmission at corticostriatal synapse.
Neuropharmacol., 36, 845 ± 851.
RODRIGUEZ-MORENO, A., SISTIAGA, A., LERMA, J. & SANCHEZ-
PRIETO, J. (1998). Switch from facilitation to inhibition of
excitatory synaptic transmission by group I mGluR desensitisa-
tion. Neuron, 21, 1477 ± 1486.
LUJAN, R., NUSSER, Z., ROBERTS, J.D.B., SHIGEMOTO, R.
&
SOMOGYI, P. (1996). Perisynaptic location of metabotropic
glutamate receptors mGluR1 and mGluR5 on dendritic and
dendritic spines in the rat hippocampus. Eur. J. Neurosci., 8,
ROMANO, C., VAN DEN POL, A.N.
& O'MALLEY, K.L. (1996).
Enhanced early developmental expression of the metabotropic
glutamate receptor mGluR5 in rat brain: protein, mRNA splice
variants, and regional distribution. J. Compar. Neurol., 367,
403 ± 412.
1
488 ± 1500.
MANAHAN-VAUGHAN, D., BEHNISCH, T.
1999). ACPD-mediated slow onset potentiation is associated
with cell death in the rat CA1 region in vivo. Neuropharmacol.,
8, 487 ± 494.
&
REYMANN, K.G.
(
SANCHEZ-PRIETO, J., BUDD, D.C., HERRERO, I., VAZQUEZ, E. &
NICHOLLS, D.G. (1996). Presynaptic receptors and the control of
glutamate exocytosis. Trends Neurosci., 19, 235 ± 239.
SAUGSTAD, J.A., KINZIE, J.M., MULVIHILL, E.R., SEGERSON, T.P. &
WESTBROOK, G.L. (1994). Cloning and expression of a new
member of the 1-2-amino-4-phosphonobutyric acid-sensitive
class of metabotropic glutamate receptors. Mol. Pharmacol.,
45, 367 ± 372.
3
MANAHAN-VAUGHAN, D. & REYMANN, K.G. (1997). Group 1
metabotropic glutamate receptors contribute to slow-onset
potentiation in the rat CA1 region in vivo. Neuropharmacol.,
3
6, 1533 ± 1538.
MANZONI, O. & BOCKAERT, J. (1995). Metabotropic glutamate
receptors inhibiting excitatory synapses in the CA1 area of rat
hippocampus. Eur. J. Neurosci., 7, 2518 ± 2523.
SAUGSTAD, J.A., KINZIE, J.M., SHINOHARA, M.M., SEGERSON, T.P.
MASU, M., TANABE, Y., TSUCHIDA, K., SHIGEMOTO, R.
&
& WESTBROOK, G.L. (1997). Cloning and expression of rat
NAKANISHI, S. (1991). Sequence and expression of a metabo-
tropic glutamate receptor. Nature, 349, 760 ± 765.
metabotropic glutamate receptor 8 reveals a distinct pharmaco-
logical pro®le. Mol. Pharmacol., 51, 119 ± 125.
SCHOEPP, D.D., GOLDSWORTHY, J., JOHNSON, B.G., SALHOFF,
MCCOOL, B.A., PIN, J.-P., HARPOLD, M.M., BRUST, P.F., STAUDER-
MAN, K.A. & LOVINGER, D.M. (1998). Rat group I metabotropic
glutamate receptors inhibit neuronal Ca 2+ channels via
multiple signal transduction pathways in HEK 293 cells. J.
Neurophysiol., 79, 379 ± 391.
C.R.
& BAKER, S.R. (1994). 3,5-dihydroxyphenylglycine is a
highly selective agonist for phosphoinositide-linked metabotro-
pic glutamate receptors in the rat hippocampus. J. Neurochem.,
63, 769 ± 772.
MONN, J.A., VALLI, M.J., MASSEY, S.M., WRIGHT, R.A., SALHOFF,
C.R., JOHNSON, B.G., HOWE, T., ALT, C.A., RHODES, G.A.,
ROBEY, R.L., TIZZANO, J.P., KALLMAN, M.J., HELTON, D.R.,
SCHOEPP, D.D. & GRIFFEY, K.R. (1997). Design, synthesis, and
pharmacological characterization of (+)-2-aminobicyclo[3.1.0]-
hexane-2,6-dicarboxylic acid (LY354740): A potent, selective,
and orally active group 2 metabotropic glutamate receptor
agonist possessing anticonvulsant and anxiolytic properties. J.
Med. Chem., 40, 528 ± 537.
SCHOEPP, D.D., JOHNSON, B.G. & MONN, J.A. (1996). (1S,3R)-1-
Aminocyclopentane-1,3-dicarboxylic acid-induced increases in
cyclic AMP formation in the neonatal rat hippocampus are
mediated by a synergistic interaction between phosphoinositide-
and inhibitory cyclic AMP-coupled mGluRs. J. Neurochem., 66,
1981 ± 1985.
SCHOEPP, D.D., JOHNSON, B.G., WRIGHT, R.A., SALHOFF, C.R.,
MAYNE, N.G., WU, S., COCKERHAM, S.L., BURNETT, J.P.,
BELEGAJE, R., BLEAKMAN, D. & MONN, J.A. (1997). LY354740
is a potent and highly selective group II metabotropic glutamate
receptor agonist in cells expressing human glutamate receptors.
Neuropharmacol., 36, 1 ± 11.
SHIGEMOTO, R., KINOSHITA, A., WADA, E., NOMURA, S., OHISHI,
H., TKADA, M., FLOR, P., NEKI, A., ABE, T., NAKANISHI, S. &
MIZUNO, N. (1997). Dierential presynaptic localization of
metabotropic glutamate receptor subtypes in the rat hippocam-
pus. J. Neurosci., 17, 7503 ± 7522.
SHIGEMOTO, R., NAKANISHI, S. & MIZUNO, N. (1992). Distribution
of the mRNA for a metabotropic glutamate receptor (mGluR1)
in the central nervous system: an in situ hybridization study in
adult and developing rat. J. Comp. Neurol., 322, 121 ± 135.
MORONI, F., LOMBARDI, G., THOMSEN, C., LEONARDI, P.,
ATTUCCI, S., PERUGINELLI, F., TORREGROSSA, S.A., PELLE-
GRINI-GIAMPIETRO, D.E., LUNEIA, R.
(
& PELLICCIARI, F.
1997). Pharmacological characterisation of 1-aminoindan-1,5-
dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol.
Exp. Therap., 281, 721 ± 729.
NAKAJIMA, Y., IWAKABE, H., AKAZAWA, C., NAWA, H., SHIGE-
MOTO, R., MIZUNO, N. & NAKANISHI, S. (1993). Molecular
characterization of a novel retinal metabotropic glutamate
receptor mGluR6 with a high agonist selectivity for L-2-amino-
4
-phosphonobutyrate. J. Biol. Chem., 268, 11868 ± 11873.
OHISHI, H., AKAZAWA, C., SHIGEMOTO, R., NAKANISHI, S. &
MIZUNO, N. (1995). Distributions of the mRNAs for L-2-amino-
SLADECZEK, F., PIN, J.-P., RECASENS, M., BOCKAERT, J. & WEISS,
Â
S. (1985). Glutamate stimulates inositol phosphate formation in
striatal neurones. Nature, 317, 717 ± 719.
SUGIYAMA, H., ITO, I. & HIRONO, C. (1987). A new type of
glutamate receptor linked to inositol phospholipid metabolism.
4
-phosphonobutyrate-sensitive metabotropic glutamate recep-
tors, mGluR4 and mGluR7, in the rat brain. J. Compar. Neurol.,
60, 555 ± 570.
OHISHI, H., SHIGEMOTO, R., NAKANISHI, S. & MIZUNO, N. (1993).
Distribution of the mRNA for metabotropic glutamate
3
a
Nature, 325, 531 ± 533.
THOMSEN, C., BOEL, E. & SUZDAK, P.D. (1994). Actions of
receptor (mGluR3) in the rat brain: an in situ hybridisation
study. J. Compar. Neurol., 335, 252 ± 266.
OVERSTREET, L.S., PASTERNAK, J.F., COLLEY, P.A., SLATER, N.T.
phenylglycine analogs at subtypes of the metabotropic glutamate
receptor family. Eur. J. Pharmacol-Molec. Pharmacol., 267, 77 ±
84.
&
TROMMER, B.L. (1997). Metabotropic glutamate receptor
mediated long-term depression in developing hippocampus.
Neuropharmacol., 36, 831 ± 844.
PALMER, E., MONAGHAN, D.T. & COTMAN, C.W. (1989). Trans-
ACPD, a selective agonist of the phosphoinositide-coupled
excitatory amino acid receptor. Eur. J. Pharmacol., 166, 585 ±
VALERIO, A., RIZZONELLI, P., PATERLINI, M., MORETTO, G.,
KNOPFEL, T., KUHN, R., MEMO, M. & SPANO, P. (1997). mGluR5
metabotropic glutamate receptor distribution in rat and human
spinal cord: a developmental study. Neurosci. Res., 28, 49 ± 57.
VAZQUEZ, E., HERRERO, I., MIRAS-PORTIGAL, M.T. & SANCHEZ-
PRIETO, J. (1995). Developmental change from inhibition to
facilitation in the presynaptic control of glutamate exocytosis by
metabotropic glutamate receptors. Neurosci., 68, 117 ± 124.
WILSCH, V.W., PIDOPLICHKO, V.I., OPITZ, T., SHINOZAKI, H. &
REYMANN, K.G. (1994). Metabotropic glutamate receptor
agonist DCG-IV as NMDA receptor agonist in immature rat
hippocampal neurons. Eur. J. Pharmacol., 262, 287 ± 291.
5
PALMER, M.J., IRVING, A.J., SEABROOK, G.R., JANE, D.E.
87.
&
COLLINGRIDGE, G.L. (1997). The group I mGlu receptor agonist
DHPG induces a novel form of LTD in the CA1 region of the
hippocampus. Neuropharmacol., 36, 1517 ± 1532.
PHILLIPS, T., MAKOFF, A., BROWN, S., REES, S. & EMSON, P. (1997).
Localisation of mGluR4 protein in the rat cerebral cortex and
hippocampus. Neuroreport, 8, 3349 ± 3354.
PIN, J.-P. & DUVOISIN, R. (1995). The metabotropic glutamate
receptors: structure and functions. Neuropharmacol., 34, 1 ± 26.
(Received May 16, 2000
Revised July 19, 2000
Accepted July 19, 2000)
British Journal of Pharmacology vol 131 (3)